Elevance Health 将来の成長

Future 基準チェック /26

Elevance Health利益と収益がそれぞれ年間12.7%と6.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に17.6% 15.8%なると予測されています。

主要情報

12.7%

収益成長率

15.8%

EPS成長率

Healthcare 収益成長	26.7%
収益成長率	6.7%
将来の株主資本利益率	17.6%
アナリストカバレッジ	Good
最終更新日	25 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BMV:ELV * - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	200,355	8,785	8,792	9,164	12
12/31/2025	187,289	7,530	7,579	8,049	15
12/31/2024	175,111	6,343	5,032	5,443	12
9/30/2024	174,015	6,418	871	2,131	N/A
6/30/2024	171,719	6,691	820	2,067	N/A
3/31/2024	171,745	6,244	2,296	3,570	N/A
12/31/2023	171,340	5,987	6,765	8,061	N/A
9/30/2023	168,626	5,996	8,246	9,514	N/A
6/30/2023	165,716	6,310	10,571	11,825	N/A
3/31/2023	160,676	6,094	11,128	12,327	N/A
12/31/2022	156,599	5,894	7,247	8,399	N/A
9/30/2022	153,251	6,166	10,395	11,589	N/A
6/30/2022	149,134	6,072	8,022	9,169	N/A
3/31/2022	144,353	6,228	7,263	8,400	N/A
12/31/2021	138,643	6,158	7,277	8,364	N/A
9/30/2021	133,883	5,518	9,480	10,505	N/A
6/30/2021	129,219	4,231	5,778	6,851	N/A
3/31/2021	124,632	4,714	9,657	10,678	N/A
12/31/2020	121,868	4,572	9,667	10,688	N/A
9/30/2020	117,449	4,955	7,108	8,202	N/A
6/30/2020	112,965	5,916	9,960	11,019	N/A
3/31/2020	109,167	4,779	5,899	6,946	N/A
12/31/2019	104,212	4,807	4,984	6,061	N/A
9/30/2019	100,165	4,298	4,151	5,197	N/A
6/30/2019	96,742	4,074	3,007	4,137	N/A
3/31/2019	94,220	3,989	2,018	3,242	N/A
12/31/2018	92,091	3,750	2,619	3,827	N/A
9/30/2018	91,409	4,556	891	2,063	N/A
6/30/2018	90,584	4,344	N/A	3,861	N/A
3/31/2018	90,061	4,145	N/A	3,712	N/A
12/31/2017	90,049	3,843	N/A	4,185	N/A
9/30/2017	89,055	2,980	N/A	5,763	N/A
6/30/2017	88,038	2,851	N/A	4,322	N/A
3/31/2017	87,083	2,777	N/A	4,599	N/A
12/31/2016	84,862	2,470	N/A	3,270	N/A
9/30/2016	83,364	2,282	N/A	3,943	N/A
6/30/2016	81,866	2,319	N/A	3,322	N/A
3/31/2016	80,412	2,398	N/A	3,825	N/A
12/31/2015	79,158	2,560	N/A	4,212	N/A
9/30/2015	77,959	2,886	N/A	3,472	N/A
6/30/2015	76,605	2,862	N/A	3,734	N/A
3/31/2015	75,066	2,734	N/A	3,632	N/A
12/31/2014	73,886	2,560	N/A	3,369	N/A
9/30/2014	72,792	2,362	N/A	3,337	N/A
6/30/2014	72,090	2,385	N/A	4,129	N/A
3/31/2014	71,307	2,453	N/A	3,483	N/A
12/31/2013	71,024	2,634	N/A	3,052	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ELV *の予測収益成長率 (年間12.7% ) は貯蓄率 ( 8.1% ) を上回っています。

収益対市場: ELV *の収益 ( 12.7% ) はMX市場 ( 11.5% ) よりも速いペースで成長すると予測されています。

高成長収益: ELV *の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: ELV *の収益 ( 6.7% ) MX市場 ( 7.2% ) よりも低い成長が予測されています。

高い収益成長: ELV *の収益 ( 6.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ELV *の自己資本利益率は、3年後には低くなると予測されています ( 17.6 %)。

Elevance Health 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023

Elevance Health Inc. Provides Earnings Guidance for Full Year 2022

Recent updates

Third quarter dividend of US$1.63 announced

Elevance Health, Inc. (NYSE:ELV) agreed to acquire CareBridge Medical Group, P.C.

Third quarter 2024 earnings released: EPS: US$4.36 (vs US$5.48 in 3Q 2023)

Elevance Health, Inc. Declares Dividend for the Fourth Quarter of 2024, Payable on December 20, 2024

Las Mercedes Medical Centers acquired Pasteur and Wellmax Medical Centers from Elevance Health, Inc. (NYSE:ELV).

Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024

Upcoming dividend of US$1.63 per share

Clayton, Dubilier & Rice and Elevance Health Announces the Introduction of Mosaic Health, a National Care Delivery Platform

Independent Director recently sold Mex$2.8m worth of stock

Second quarter dividend of US$1.63 announced

Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024

Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024

Insufficient new directors

Upcoming dividend of US$1.63 per share

Insufficient new directors

Insider recently sold Mex$117m worth of stock

First quarter dividend of US$1.63 announced

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Insufficient new directors

Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024

StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc.

StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc.

Senior VP recently sold Mex$7.8m worth of stock

Insufficient new directors

Upcoming dividend of US$1.63 per share

Full year 2023 earnings released: EPS: US$25.38 (vs US$24.56 in FY 2022)

Elevance Health, Inc., Annual General Meeting, May 15, 2024

Insufficient new directors

Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Senior VP recently sold Mex$8.7m worth of stock

Insufficient new directors

Third quarter 2023 earnings released: EPS: US$5.48 (vs US$6.75 in 3Q 2022)

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023

Insufficient new directors

Upcoming dividend of US$1.48 per share at 1.3% yield

Insufficient new directors

Elevance Health, Inc. Announces Executive Changes

Independent Director recently sold Mex$2.5m worth of stock

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$7.79 (vs US$6.87 in 2Q 2022)

Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023

Upcoming dividend of US$1.48 per share at 1.3% yield

First quarter 2023 earnings released: EPS: US$8.30 (vs US$7.48 in 1Q 2022)

Insufficient new directors

Upcoming dividend of US$1.48 per share at 1.3% yield

Elevance Health, Inc., Annual General Meeting, May 10, 2023

Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx.

Full year 2022 earnings released: EPS: US$24.82 (vs US$25.04 in FY 2021)

Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023

Elevance Health Inc. (NYSE:ELV) entered into a definitive agreement Louisiana Health Service and Indemnity Company.

Elevance Health Inc. to Report Q4, 2022 Results on Jan 25, 2023

Insufficient new directors

Insufficient new directors

Upcoming dividend of US$1.28 per share

Insufficient new directors

Elevance Health Inc. (NYSE:ELV) entered into an agreement to acquire BioPlus Specialty Pharmacy Services, LLC from CarepathRx.

Elevance Health, Inc. Appoints Deanna Strable-Soethout as an Independent Director, Effective November 1, 2022

Elevance Health Inc. Provides Earnings Guidance for Full Year 2022

Elevance Health Inc. to Report Q3, 2022 Results on Oct 19, 2022

Insufficient new directors

Insufficient new directors

Insufficient new directors

Second quarter 2022 earnings released

Elevance Health Inc. Declares Third Quarter 2022 Dividend, Payable on September 23, 2022

Elevance Health Inc. to Report Q2, 2022 Results on Jul 20, 2022